Singapore Oncology Consultants

What Singapore Oncology Consultants does

Singapore Oncology Consultants Pte Ltd, operating as Icon Cancer Centre Singapore, is a private oncology healthcare provider wholly owned by Icon Group, an Australian-headquartered oncology network with operations across seven Asia-Pacific countries (Australia, New Zealand, Singapore, Malaysia, Indonesia, UK, China). The company delivers comprehensive cancer care across the full treatment continuum: chemotherapy, radiation therapy, immunotherapy, targeted therapies, hormone therapy, and surgical oncology, supported by advanced radiation therapy techniques including HyperArc, TomoTherapy, Stereotactic Radiation Therapy, Deep Inspiration Breath Hold (DIBH), Brachytherapy, and Triggered Imaging. Adjacent offerings include Nuclear Medicine & PET-CT diagnostics, Palliative Medicine, the Young Women's Cancer Program, and dedicated sub-brands Icon Haematology (blood disorders) and Icon Health Screening (preventive screening).

The business operates on a professional fee-for-service model, billing private patients on a pay-as-you-go basis with quote-based pricing that varies by cancer type, modality, duration, and complexity. Patient access is enabled through direct appointment channels (phone, WhatsApp, email, online form) and through commercial relationships with multiple insurance partners. Marketing is conducted via organic social media (Facebook, Instagram, YouTube), email newsletters, and an extensive online cancer information library. The centre targets both domestic Singaporean cancer patients and regional medical travellers, with multilingual support across English, Bahasa Indonesia, Vietnamese, and Simplified Chinese. Icon Cancer Centre Singapore is the only oncology provider in Singapore with ACHSI (Australian Council on Healthcare Standards International) accreditation, positioning the business on international quality benchmarks and combining Australian and Singaporean clinical approaches.

Name

Singapore Oncology Consultants

Legal name

Singapore Oncology Consultants Pte Ltd

Website

http://www.singaporeoncology.com

Company type

Private

Operating status

Operating

Short description

Singapore Oncology Consultants Pte Ltd, operating as Icon Cancer Centre Singapore, is a private oncology healthcare provider delivering comprehensive cancer treatment, diagnostic, and supportive care services to private patients in Singapore as part of Icon Group's seven-country regional network.

Ownership category

akta.pro rank

Product category

Oncology Services

NAICS

Offices of Physicians (62111), Offices of Physicians (except Mental Health Specialists) (621111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI), Gynecologic Oncology & Women’s Cancer Centers (HLAFAJAK)

Keywords

• Cancer treatment services
• Radiation oncology
• Medical oncology
• Cancer diagnostics
• Haematology services

Headquarters

HQ city

Singapore

HQ country

Singapore

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Oncology Treatment Services: Revenue generated from providing comprehensive cancer treatment services including chemotherapy, radiation therapy, immunotherapy, targeted therapies, hormone therapy, and surgery. Services are provided on a fee-for-service basis for private patients, with billing based on treatment type, duration, and complexity.
2. Diagnostic Services: Revenue from diagnostic imaging services including Nuclear Medicine and PET-CT scans used for cancer diagnosis and staging.
3. Health Screening Services: Revenue from preventive health screening services offered through Icon Health Screening.
4. Palliative Medicine Services: Specialized palliative care services for advanced cancer patients managing symptoms and improving quality of life.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Singapore Oncology Consultants (operating as Icon Cancer Centre Singapore) provides private comprehensive cancer care including medical oncology (chemotherapy, immunotherapy, targeted therapies, hormone therapy), radiation oncology, cancer surgery, nuclear medicine and PET-CT imaging, haematology, palliative medicine, and cancer health screening delivered from treatment centres in Singapore as part of the Icon Group network.

Product overview

Icon Cancer Centre Singapore is part of the Icon Group network and operates as a comprehensive oncology care provider offering a unified platform of cancer treatment services. The centre delivers treatment through multiple sub-brands including Icon Haematology (blood disorders), Icon Health Screening (preventive care), and specialised programs such as the Young Women's Cancer Program. Core treatments include chemotherapy, radiation therapy, immunotherapy, targeted therapies, hormone therapy, and surgery, supported by advanced radiation therapy techniques including HyperArc, Stereotactic Radiation Therapy, Deep Inspiration Breath Hold (DIBH), Brachytherapy, Triggered Imaging, and TomoTherapy. Additional services include Nuclear Medicine & PET-CT diagnostics and Palliative Medicine. The centre positions itself as the only oncology provider in Singapore with ACHSI accreditation, combining Singaporean and Australian approaches to patient-centered cancer care.

Differentiator

Problem solved

Functional benefit

Brands

• Icon Haematology: Specialized haematology services for blood disorders including haemochromatosis, thrombosis, myelodysplasia, and anaemia.
• Icon Health Screening
• Icon Haematology (SG)

Products and services

• Chemotherapy Systemic drug treatment administered to cancer patients under oncologist supervision. Intended for individuals diagnosed with cancer requiring systemic anti-cancer therapy.
• Radiation Therapy Radiation-based cancer treatment delivered by radiation oncologists. Intended for cancer patients who require or may benefit from radiotherapy as part of their treatment plan.
• Immunotherapy Immune-based cancer treatment that uses the patient's own immune system to fight cancer. Intended for cancer patients eligible for immune-modulating therapy.
• Targeted Therapies Precision drug treatment targeting specific genetic or molecular markers of cancer cells. Intended for cancer patients with targetable tumour characteristics.
• Hormone Therapy Hormonal drug treatment for hormone-sensitive cancers. Intended for patients with hormone-driven cancers such as breast or prostate cancer.
• Cancer Surgery Surgical removal of tumours and cancer-related procedures performed by surgical oncologists. Intended for cancer patients requiring surgical intervention as part of their treatment.
• Nuclear Medicine & PET-CT Nuclear medicine diagnostic imaging and PET-CT scans for cancer diagnosis, staging, and treatment monitoring. Intended for cancer patients and individuals requiring advanced diagnostic imaging.
• Palliative Medicine Specialist care focused on relieving symptoms and improving quality of life for patients with serious or advanced cancer. Intended for cancer patients experiencing treatment-related or disease-related symptoms.
• Icon Haematology Specialist haematology services for the diagnosis and treatment of blood cancers and benign blood disorders. Intended for patients with haematological conditions including leukaemia, lymphoma, and myeloma.
• Icon Health Screening Health screening services including cancer screening for early detection. Intended for individuals seeking preventive health and cancer screening assessments.
• Young Women's Cancer Program A dedicated program addressing the unique cancer care needs of young women diagnosed with cancer. Intended for young women cancer patients requiring tailored clinical and supportive care.

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

One partnership is on record.

• Insurance PartnerscoreChannel Partner/ Reseller/ DistributorIcon Cancer Centre Singapore partners with various insurance providers to enable patient access to cancer treatment services. The centre has an 'Insurance Partners' section on its website indicating commercial arrangements with multiple insurance companies for coverage of oncology treatment services.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Parkway Cancer Centre: Private oncology provider in Singapore operated under IHH Healthcare/Parkway Pantai, offering chemotherapy, radiotherapy, and surgical oncology across multiple specialist cancer types. Directly comparable to Icon Cancer Centre Singapore in service mix, private-pay model, and Singapore-only footprint.
• OncoCare Cancer Centre: Specialist private oncology practice in Singapore providing medical oncology, haemato-oncology, and supportive care. Closely comparable in scale, clinical specialisation, and target patient segments as a private cancer specialist.
• Icon Cancer Centre Australia: Australian flagship of Icon Group, offering the same comprehensive private oncology platform (chemo, radiation including HyperArc/TomoTherapy, immunotherapy, surgery). Directly comparable as the parent group's other core operating entity in a different but adjacent regulatory and reimbursement environment.

Broad incumbents

• National Cancer Centre Singapore (NCCS): Singapore's flagship public-sector specialty cancer hospital under SingHealth. Competes indirectly with Icon SG by offering heavily subsidised oncology care; comparison illuminates the public/private pricing divide Icon SG must navigate.
• Mount Elizabeth Hospital (IHH Healthcare): Large private tertiary hospital in Singapore offering oncology as part of broader multi-specialty services under IHH Healthcare. Comparable as a private-pay Singapore provider with oncology capability, though embedded in a general hospital rather than as a focused specialist.
• Farrer Park Hospital: Singapore private hospital with an oncology centre offering chemotherapy, radiotherapy, and targeted therapy. Overlaps with Icon SG in modality and target private-pay patient base but operates within a general hospital delivery model.
• Gleneagles Hospital Singapore: Singapore private hospital under Parkway Pantai/IHH offering oncology services including radiotherapy. Comparable as a competing private-pay venue for cancer treatment, though operating as a general hospital rather than a dedicated oncology centre.

Regional players

• Bumrungrad International Hospital: Leading private tertiary hospital in Bangkok with a large oncology centre and significant medical tourism flow from Southeast Asia. Comparable as a regional private oncology destination that competes for cross-border patients Icon SG may also target.
• Peter MacCallum Cancer Centre: Australia's only public hospital dedicated to cancer treatment and a flagship oncology research centre. Comparable in clinical depth and modality breadth to Icon SG's Singapore operations, though public-funded and Australian rather than Singaporean.

Emerging players

• Lucence: Singapore-headquartered precision oncology company offering molecular profiling and liquid biopsy diagnostics. Comparable as a Singapore-based oncology-focused player targeting the same patient and clinician ecosystem, though at the diagnostics stage rather than treatment delivery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/c/IconCancerCentreSingapore
• Facebookfacebook.com/IconCancerCentreSingapore
• Instagraminstagram.com/iconcancercentre_singapore

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Singapore Oncology Consultants